参考文献/References:
[1] 张 梅,吴 静,张 笑,等.2018年中国成年居民高血压患病与控制状况研究[J].中华流行病学杂志,2021,42(10):1780-1789.
[2] 易胜利,邓 玮.心肌纤维化发病机制研究进展[J].现代医药卫生,2022,38(12):2051-2055.
[3] Istratoaie O,Pirici I,Ofiteru AM,et al.Evaluation of cardiac microvasculature in patients with diffuse myocardial fibrosis[J].Embryol,2016,57(4):1351-1356.
[4] 张 妍,周纳纳,韩 茹,等.益心附葶饮对主动脉缩窄大鼠心肌纤维化及p38MAPK/NF-κB p65信号通路的影响[J].陕西中医,2022,43(3):287-291.
[5] An Z,Yang G,Zheng HK,et al.Biomarkers in patients with myocardial fibrosis[J].Open Life Sciences,2017,12(1):337-344.
[6] Foronjy RF,Sun J,Armiento J.Transgenic expression of matrix metalloproteinase-1 inhibits myocardial fibrosis and prevents the transition to heart failure in a pressure overload mouse model[J].Hypertens Res,2008,31:725-735.
[7] Ogawa K,Chen FF,Kuang CZ,et al.Suppression of matrix metalloproteinase-9 transcription by transforming growth factor-β is mediated by a nuclear factor-κB site[J].Biochemical Journal,2004,381(2):413-422.
[8] Gao Q,Cui XY,Dong F,et al.Efficacy and safety of bushenjiangya-optimized granule granule for left ventricular diastolic dysfunction in hypertensive patients:A double-blind,randomized,placebo-controlled trial[J].Evid Based Complement Alternat Med,2020,18:7190352.
[9] 崔晓云,范文英,李品慧,等.益气活血补肾降压方治疗高血压左室舒张功能障碍的临床研究[J].中华中医药杂志,2018,33(3):1152-1155.
[10] 周 鹍,范文英,孟 妍,等.益气活血法治疗高血压伴无症状舒张功能不全的临床研究[J].中西医结合心脑血管病杂志,2017,15(22):2811-2812.
[11] 范金茹,王行宽,熊国强.高血压左室肥厚中医病名、病位、病因病机探讨[J].中医药通报,2005,4(2):19-21.
[12] 周明龙,姚祖培.活血化瘀方药防治高血压心肌纤维化研究进展[J].中西医结合心脑血管病杂志,2013,11(2):209-211.
[13] 吴美芳,吕仕超,张军平.心肌纤维化中医诊疗思路探析[J].时珍国医国药,2015,26(3):677-679.
[14] 王奇林,董昌武,徐 慧,等.滋阴潜阳方对自发性高血压大鼠心肌纤维化相关蛋白表达的影响[J].安徽中医药大学学报,2023,42(3):83-87.
[15] 蒋嘉烨,王现珍,罗珊珊,等.半夏白术天麻汤对自发性高血压大鼠左心室肥厚的影响[J].中国中西医结合杂志,2010,21(10):1061-1066.
[16] 崔晓云,谭 弘,张学江,等.益气活血-高血压舒张功能障碍的中医药防治新思路[J].中国中医基础医学杂志,2015,21(2):181-182.
[17] 刘 静,徐江林,石晓路,等.益气活血法对舒张性心力衰竭大鼠心肌细胞钙稳态的影响[J].北京中医药大学学报,2022,45(2):165-175.
[18] 孙娅楠,农一兵,崔晓云,等.黄芪对乳鼠肥大心肌细胞钙瞬变及钙调蛋白激酶Ⅱ的影响[J].中国中医基础医学杂志,2013,19(1):44-46.
[19] 刘 静.基于心肌细胞钙稳态研究益气活血药对舒张性心功能不全的干预机制[D].北京:北京中医药大学,2017.
[20] 付亚梦,刘 昕.左房时相功能诊断冠状动脉粥样硬化性心脏病患者左室舒张功能障碍的价值[J].临床超声医学杂志,2023,25(1):39-43.
[21] 中华医学会超声医学分会超声心动图学组,中国医师协会心血管分会超声心动图专业委员会.超声心动图评估心脏收缩和舒张功能临床应用指南[J].中华超声影像学杂志,2020,29(6):461-477.
[22] Mark S,Ben C,Stuart AC.Targeting cardiac fibrosis in heart failure with preserved ejection fraction:Mirage or miracle?[J].EMBO Mol Med,2020,12:10865.
[23] 丁秀婷,刘 璠,刘建一,等.银杏内酯B对自发性高血压大鼠心肌纤维化及左心室肥厚的影响研究[J].陕西医学杂志,2017,46(7):823-825.
[24] 朱力权.益气活血补肾法治疗高血压左室舒张功能障碍的临床效果[J].内蒙古中医药,2021,40(7):13-14.
[25] 宋晓龙,宋 俊,潘仁友,等.利心水方治疗冠心病心力衰竭疗效及对患者心肌纤维化、心肌重构的影响[J].陕西中医,2022,43(2):197-200.
[26] Weber KT,Janicki JS,Shroff SG,et al.Collagen remodeling of the pressure-overloaded hypertrophied nonhuman primate myocardium[J].Circ Res,1988,62:757-765.
[27] Caulfield JB,Janicki JS.Structure and function of myocardial fibrillar collagen[J].Technol Health Care,1997,5:95-113.
[28] Chiao YA,Ramirez TA,Zamilpa R,et al.Matrix metalloproteinase-9 deletion attenuates myocardial fibrosis and diastolic dysfunction in ageing mice[J].Cardiovascular Research,2012,96(3):444-455.
[29] Munch J,Avanesov M,Bannas P,et al.Serum matrix metalloproteinases as quantitative biomarkers for myocardial fibrosis and sudden cardiac death risk stratification in patients with hypertrophic cardiomyopathy[J].Card Fail,2016,22:845-850.
[30] Benjamin EJ,Muntner P,Alonso A,et al.Heart disease and stroke statistics-2019 update:A report from the American Heart Association[J].Circulation,2019,139(10):562-528.
[31] Dziaio E,Tkacz K,Biszczuk P.Crosstalk between the TGF-β and WNT signalling pathways during cardiac fibrogenesis[J].Acta Biochim Pol,2018,65:341-349.
[32] Zhao M,Zheng S,Yang J,et al.Suppression of TGF-beta1/Smad signaling pathway by sesamin contributes to the attenuation of myocardial fibrosis in spontaneously hypertensive rats[J].PLoS One,2015,10(3):121312.
[33] Zhang Y,Shao L,Ma A,et al.Telmisartan delays myocardial fibrosis in rats with hypertensive left ventricular hypertrophy by TGF-beta1/Smad signal pathway[J].Hypertens Res,2014,37(1):43-49.
[34] 张 丽,彭 静,金 璟,等.妊娠期高血压疾病孕妇血清和胎盘组织中血管内皮生长因子、糖基化终末产物、转化生长因子-β1表达及其与病情严重程度相关性研究[J].陕西医学杂志,2022,51(8):953-956,960.